At present time, for the treatment of hypertension, there are a number of active angiotensin II (AT II) receptor antagonists (candesartan, losartan, and so on) which are available representing therapeutic effect in the interference of the renin-angiotensin-aldosterone system to lower the BP [15, 16]. The gene discussed is REN; the disease is hypertensive disorder.